Workshop D – Microbiome Macroeconomics: Analysing Industry Trends to Inform Microbiome Drug Development Strategy
Time: 4:00 pm
day: Workshop Track 4
Details:
With industry trends serving as crucial guideposts for strategic decision-making in microbiome drug development, seize the opportunity in this workshop to benchmark effective practices and explore:
- Trend-Informed Pipeline Strategy Beyond Drug Development: Examine the latest industry trends shaping microbiome drug development, as well as across the microbiome product field, and how these inform strategic decisions in optimizing drug pipelines
- Application and Modality Insights: Gain preliminary insights into the therapeutic applications and platforms showing promise, identifying areas of opportunity and potential for innovation
- Navigating Bottlenecks: Delve into the challenges and bottlenecks currently faced in microbiome drug development, fostering discussions on overcoming hurdles and strategizing for improved pipeline efficiency
Featuring a Case Study: Vertical Integration to Reduce Costs, Improve Turnaround Times, Increase Flexibility & Generate Revenue: A Biopharma Case Study
- Reliance on service providers introduces timeline and technical risk into development programs that can be difficult to mitigate
- Insourcing represents an attractive option to manage risk, and in some cases, convert expenses to revenue
- Vertical integration allows excess GMP manufacturing facility capacity to be used for providing cost-effective manufacturing to other early-stage biopharmas
Participate to dissect industry trends, garner valuable insights, and collectively shape a forward-thinking pipeline strategy for the success of your microbiome drug development program.
